Hybio Pharmaceutical Co (SZSE:300199) Margin of Safety % (DCF Earnings Based) : N/A (As of Apr. 30, 2025)

View and export this data going back to 2011. Start your Free Trial

What is Hybio Pharmaceutical Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Hybio Pharmaceutical Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

Competitive Comparison of Hybio Pharmaceutical Co's Margin of Safety % (DCF Earnings Based)

For the Drug Manufacturers - Specialty & Generic subindustry, Hybio Pharmaceutical Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hybio Pharmaceutical Co's Margin of Safety % (DCF Earnings Based) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hybio Pharmaceutical Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Hybio Pharmaceutical Co's Margin of Safety % (DCF Earnings Based) falls into.

Save Embed

;

Save Embed

;

Hybio Pharmaceutical Co Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of Hybio Pharmaceutical Co's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Hybio Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hybio Pharmaceutical Co Ltd (SZSE:300199) » Definitions » Margin of Safety % (DCF Earnings Based)

Traded in Other Exchanges

N/A

Address

4th Floor, Office Building, Hanyu Biomedical Park, Middle District, High-tech Industrial Park, Nanshan District, Guangdong Province, Shenzhen, CHN, 518057

Website

http://www.hybio.com.cn

Hybio Pharmaceutical Co Ltd is engaged in manufacturing and sale of peptide products. The company's peptide finished dosage products include digestive system agents, immune modulators, hormone and endocrine modulators, antiviral agents, and hemostatic products. It also provides peptide CRO and CMO services, as well as API products.

Executives

Ceng Shao Gui	Director
Ceng Shao Bin	Director
Ceng Shao Qiang	Director
Zhu Wen Feng	Directors, Directors, and Executives
Tao An Jin	Executives
Wei Hong	Executives
Yuan Jian Cheng	Directors, executives
Liu Jian	Executives
Yang Jun	Executives
	Executives
Zhu Ning	Supervisors
Yang Chun Hai	Supervisors
Cai Lei	Directors, executives

Hybio Pharmaceutical Co Headlines

No Headlines